| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 2.77e-25 | 46 | 43 | 13 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 COL27A1 | 1.63e-18 | 188 | 43 | 14 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 COL27A1 | 2.62e-09 | 891 | 43 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 2.95e-04 | 12 | 43 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | heparin binding | 7.63e-04 | 192 | 43 | 4 | GO:0008201 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL28A1 NOTCH1 COL27A1 | 8.23e-15 | 377 | 41 | 14 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL28A1 NOTCH1 COL27A1 | 8.54e-15 | 378 | 41 | 14 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL28A1 NOTCH1 COL27A1 | 8.86e-15 | 379 | 41 | 14 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.89e-11 | 12 | 41 | 5 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 2.03e-10 | 18 | 41 | 5 | GO:0038065 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 8.31e-09 | 76 | 41 | 6 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 1.16e-05 | 3 | 41 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 1.68e-05 | 277 | 41 | 6 | GO:0048705 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL3A1 PCDHA10 HOXB6 OTX1 COL11A1 ELN COL11A2 GNAS GLI1 NOTCH1 COL27A1 | 2.61e-05 | 1269 | 41 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | connective tissue development | 5.57e-05 | 343 | 41 | 6 | GO:0061448 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 6.33e-05 | 351 | 41 | 6 | GO:0048562 | |
| GeneOntologyBiologicalProcess | embryo development | COL3A1 TANC2 HOXB6 OTX1 KMT2D COL11A1 GNAS LATS2 GLI1 NOTCH1 COL27A1 | 8.13e-05 | 1437 | 41 | 11 | GO:0009790 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | DAB2IP COL3A1 COL4A1 COL4A2 TXNIP COL4A3 COL4A5 COL4A6 LATS2 NOTCH1 | 8.29e-05 | 1186 | 41 | 10 | GO:0007167 |
| GeneOntologyBiologicalProcess | circulatory system development | DAB2IP COL3A1 COL4A1 COL4A2 COL4A3 PCDHA10 COL11A1 ELN GLI1 NOTCH1 COL27A1 | 8.39e-05 | 1442 | 41 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | skin development | 8.85e-05 | 373 | 41 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 9.43e-05 | 747 | 41 | 8 | GO:0007169 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.04e-04 | 46 | 41 | 3 | GO:0003176 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.07e-04 | 561 | 41 | 7 | GO:0048568 | |
| GeneOntologyBiologicalProcess | cartilage development | 1.15e-04 | 243 | 41 | 5 | GO:0051216 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.34e-04 | 50 | 41 | 3 | GO:1905314 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 1.39e-04 | 133 | 41 | 4 | GO:0002062 | |
| GeneOntologyBiologicalProcess | cardiac ventricle formation | 1.72e-04 | 10 | 41 | 2 | GO:0003211 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 1.72e-04 | 10 | 41 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.19e-04 | 59 | 41 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 2.44e-04 | 154 | 41 | 4 | GO:0090090 | |
| GeneOntologyBiologicalProcess | cardiac chamber formation | 3.46e-04 | 14 | 41 | 2 | GO:0003207 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.53e-04 | 906 | 41 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | head development | 3.88e-04 | 919 | 41 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 4.18e-04 | 929 | 41 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | blood vessel development | 4.18e-04 | 929 | 41 | 8 | GO:0001568 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 4.62e-04 | 713 | 41 | 7 | GO:0048598 | |
| GeneOntologyBiologicalProcess | glomerulus development | 4.81e-04 | 77 | 41 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | heart valve development | 5.00e-04 | 78 | 41 | 3 | GO:0003170 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 5.09e-04 | 957 | 41 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | DAB2IP COL3A1 COL4A1 COL4A2 COL4A3 PCDHA10 GNAS LATS2 NOTCH1 COL27A1 | 5.11e-04 | 1483 | 41 | 10 | GO:0048646 |
| GeneOntologyBiologicalProcess | layer formation in cerebral cortex | 5.14e-04 | 17 | 41 | 2 | GO:0021819 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 5.19e-04 | 79 | 41 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | aorta development | 5.39e-04 | 80 | 41 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | vasculature development | 5.53e-04 | 969 | 41 | 8 | GO:0001944 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 5.97e-04 | 195 | 41 | 4 | GO:0030178 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 7.11e-04 | 88 | 41 | 3 | GO:0003208 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 8.36e-04 | 93 | 41 | 3 | GO:0060415 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.03e-03 | 817 | 41 | 7 | GO:0048514 | |
| GeneOntologyBiologicalProcess | notochord development | 1.03e-03 | 24 | 41 | 2 | GO:0030903 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 1.09e-03 | 102 | 41 | 3 | GO:0048644 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle morphogenesis | 1.12e-03 | 25 | 41 | 2 | GO:0003214 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell membrane repolarization | 1.12e-03 | 25 | 41 | 2 | GO:0060307 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.27e-03 | 615 | 41 | 6 | GO:0001501 | |
| GeneOntologyBiologicalProcess | membrane repolarization during cardiac muscle cell action potential | 1.31e-03 | 27 | 41 | 2 | GO:0086013 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 1.32e-03 | 109 | 41 | 3 | GO:0048704 | |
| GeneOntologyBiologicalProcess | brain development | 1.38e-03 | 859 | 41 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.46e-03 | 1125 | 41 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | cerebral cortex radial glia-guided migration | 1.62e-03 | 30 | 41 | 2 | GO:0021801 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell membrane repolarization | 1.62e-03 | 30 | 41 | 2 | GO:0099625 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell membrane repolarization | 1.62e-03 | 30 | 41 | 2 | GO:0099623 | |
| GeneOntologyBiologicalProcess | telencephalon glial cell migration | 1.62e-03 | 30 | 41 | 2 | GO:0022030 | |
| GeneOntologyBiologicalProcess | organ growth | 1.64e-03 | 256 | 41 | 4 | GO:0035265 | |
| GeneOntologyBiologicalProcess | membrane repolarization during action potential | 1.73e-03 | 31 | 41 | 2 | GO:0086011 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.91e-03 | 124 | 41 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | developmental growth | 1.93e-03 | 911 | 41 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | epidermis development | 2.11e-03 | 461 | 41 | 5 | GO:0008544 | |
| GeneOntologyCellularComponent | complex of collagen trimers | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL28A1 COL27A1 | 3.07e-28 | 21 | 43 | 12 | GO:0098644 |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 MSR1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 1.32e-23 | 88 | 43 | 14 | GO:0005581 |
| GeneOntologyCellularComponent | collagen type IV trimer | 5.26e-17 | 6 | 43 | 6 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.47e-15 | 8 | 43 | 6 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.47e-15 | 8 | 43 | 6 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.47e-15 | 8 | 43 | 6 | GO:0098645 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 4.82e-14 | 12 | 43 | 6 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 4.82e-14 | 12 | 43 | 6 | GO:0098643 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 7.71e-14 | 332 | 43 | 13 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 COL27A1 | 1.53e-12 | 530 | 43 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 COL27A1 | 2.65e-11 | 656 | 43 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 COL27A1 | 2.76e-11 | 658 | 43 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 5.25e-09 | 122 | 43 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL3A1 COL4A1 COL4A2 COL4A3 SHROOM4 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL28A1 COL27A1 | 5.57e-08 | 1187 | 43 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type V trimer | 2.47e-05 | 4 | 43 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 4.12e-05 | 5 | 43 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular fiber | 2.48e-03 | 1179 | 43 | 8 | GO:0099512 | |
| HumanPheno | Lenticonus | 4.41e-08 | 10 | 21 | 4 | HP:0001142 | |
| HumanPheno | Glomerular basement membrane lamellation | 6.04e-08 | 3 | 21 | 3 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 6.04e-08 | 3 | 21 | 3 | HP:0011501 | |
| HumanPheno | Abnormality of lens shape | 6.30e-07 | 18 | 21 | 4 | HP:0011526 | |
| HumanPheno | Thickened glomerular basement membrane | 1.30e-05 | 12 | 21 | 3 | HP:0004722 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 1.62e-05 | 2 | 21 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 1.62e-05 | 2 | 21 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 1.62e-05 | 2 | 21 | 2 | HP:0006756 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 1.68e-05 | 13 | 21 | 3 | HP:0033282 | |
| HumanPheno | Glomerular subepithelial deposits | 2.14e-05 | 14 | 21 | 3 | HP:0033603 | |
| HumanPheno | Vulvar neoplasm | 4.84e-05 | 3 | 21 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 4.84e-05 | 3 | 21 | 2 | HP:0032141 | |
| HumanPheno | Thin glomerular basement membrane | 4.84e-05 | 3 | 21 | 2 | HP:0012577 | |
| HumanPheno | Glomerular deposits | 6.58e-05 | 20 | 21 | 3 | HP:0030949 | |
| HumanPheno | Small nail | 6.85e-05 | 183 | 21 | 6 | HP:0001792 | |
| HumanPheno | Osteoarthritis | 1.23e-04 | 65 | 21 | 4 | HP:0002758 | |
| HumanPheno | Cataract | COL4A1 COL4A3 SHROOM4 COL4A4 COL4A5 COL4A6 COL11A1 ELN COL11A2 GNAS NOTCH1 | 1.34e-04 | 822 | 21 | 11 | HP:0000518 |
| HumanPheno | Short phalanx of finger | 1.47e-04 | 306 | 21 | 7 | HP:0009803 | |
| HumanPheno | Ascending aortic dissection | 1.48e-04 | 26 | 21 | 3 | HP:0004933 | |
| HumanPheno | Abnormal lens morphology | COL4A1 COL4A3 SHROOM4 COL4A4 COL4A5 COL4A6 COL11A1 ELN COL11A2 GNAS NOTCH1 | 1.58e-04 | 837 | 21 | 11 | HP:0000517 |
| HumanPheno | Degenerative vitreoretinopathy | 1.61e-04 | 5 | 21 | 2 | HP:0007964 | |
| HumanPheno | Abnormal ascending aorta morphology | 1.66e-04 | 27 | 21 | 3 | HP:0031784 | |
| HumanPheno | Chest pain | 1.88e-04 | 137 | 21 | 5 | HP:0100749 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 1.91e-04 | 319 | 21 | 7 | HP:0009767 | |
| HumanPheno | Esophageal neoplasm | 2.06e-04 | 29 | 21 | 3 | HP:0100751 | |
| HumanPheno | Myopia | 2.41e-04 | 447 | 21 | 8 | HP:0000545 | |
| HumanPheno | Abnormal fingernail morphology | 2.43e-04 | 230 | 21 | 6 | HP:0001231 | |
| HumanPheno | Porencephalic cyst | 2.77e-04 | 32 | 21 | 3 | HP:0002132 | |
| HumanPheno | Hypoplastic toenails | 3.03e-04 | 82 | 21 | 4 | HP:0001800 | |
| HumanPheno | Dumbbell-shaped long bone | 3.36e-04 | 7 | 21 | 2 | HP:0000947 | |
| HumanPheno | Uterine prolapse | 3.36e-04 | 7 | 21 | 2 | HP:0000139 | |
| HumanPheno | Genital hernia | 4.47e-04 | 8 | 21 | 2 | HP:0100823 | |
| HumanPheno | Anti-smooth muscle antibody positivity | 4.47e-04 | 8 | 21 | 2 | HP:0003262 | |
| HumanPheno | Aplasia/Hypoplasia of the nails | 4.54e-04 | 258 | 21 | 6 | HP:0008386 | |
| HumanPheno | Neoplasm of head and neck | 4.64e-04 | 38 | 21 | 3 | HP:0012288 | |
| HumanPheno | Aortic dissection | 5.41e-04 | 40 | 21 | 3 | HP:0002647 | |
| HumanPheno | Bronchiolitis | 7.14e-04 | 10 | 21 | 2 | HP:0011950 | |
| HumanPheno | Schizencephaly | 7.14e-04 | 10 | 21 | 2 | HP:0010636 | |
| HumanPheno | Vaginal neoplasm | 7.14e-04 | 10 | 21 | 2 | HP:0100650 | |
| HumanPheno | Abnormal urine cytology | 8.15e-04 | 188 | 21 | 5 | HP:0012614 | |
| HumanPheno | Hematuria | 8.15e-04 | 188 | 21 | 5 | HP:0000790 | |
| HumanPheno | Midface retrusion | 8.63e-04 | 291 | 21 | 6 | HP:0011800 | |
| MousePheno | hematuria | 1.46e-09 | 19 | 39 | 5 | MP:0005161 | |
| MousePheno | podocyte foot process effacement | 3.57e-06 | 38 | 39 | 4 | MP:0008140 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 6.48e-06 | 44 | 39 | 4 | MP:0011348 | |
| MousePheno | abnormal podocyte foot process morphology | 1.59e-05 | 55 | 39 | 4 | MP:0008059 | |
| MousePheno | albuminuria | 2.74e-05 | 63 | 39 | 4 | MP:0002871 | |
| MousePheno | abnormal ear morphology | 3.78e-05 | 470 | 39 | 8 | MP:0002102 | |
| MousePheno | abnormal podocyte morphology | 4.15e-05 | 70 | 39 | 4 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 4.15e-05 | 70 | 39 | 4 | MP:0011497 | |
| MousePheno | buphthalmos | 4.53e-05 | 4 | 39 | 2 | MP:0009274 | |
| MousePheno | abnormal aortic valve morphology | 4.64e-05 | 72 | 39 | 4 | MP:0002747 | |
| MousePheno | abnormal heart left ventricle outflow tract morphology | 4.64e-05 | 72 | 39 | 4 | MP:0010429 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 5.61e-05 | 27 | 39 | 3 | MP:0011409 | |
| MousePheno | renal glomerular synechia | 7.54e-05 | 5 | 39 | 2 | MP:0011483 | |
| MousePheno | anterior polar cataract | 7.54e-05 | 5 | 39 | 2 | MP:0010259 | |
| MousePheno | renal tubule atrophy | 7.74e-05 | 30 | 39 | 3 | MP:0011346 | |
| MousePheno | abnormal glomerular mesangium morphology | 8.11e-05 | 83 | 39 | 4 | MP:0011339 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 8.55e-05 | 31 | 39 | 3 | MP:0011349 | |
| MousePheno | pale kidney | 1.03e-04 | 33 | 39 | 3 | MP:0004969 | |
| MousePheno | abnormal blood vessel morphology | COL3A1 COL4A1 COL4A2 COL4A3 IL11RA COL4A5 PCDHA10 ELN FOLH1 KCNH2 COL28A1 NOTCH1 COL27A1 | 1.09e-04 | 1472 | 39 | 13 | MP:0001614 |
| MousePheno | polar cataract | 1.13e-04 | 6 | 39 | 2 | MP:0010258 | |
| MousePheno | renal cast | 1.13e-04 | 34 | 39 | 3 | MP:0011402 | |
| MousePheno | artery stenosis | 1.24e-04 | 35 | 39 | 3 | MP:0006135 | |
| MousePheno | abnormal heart ventricle outflow tract morphology | 1.43e-04 | 96 | 39 | 4 | MP:0010224 | |
| MousePheno | sensorineural hearing loss | 1.46e-04 | 37 | 39 | 3 | MP:0004740 | |
| MousePheno | abnormal semilunar valve morphology | 1.49e-04 | 97 | 39 | 4 | MP:0002746 | |
| MousePheno | sensorineural hearing impairment | 1.58e-04 | 38 | 39 | 3 | MP:0006329 | |
| MousePheno | abnormal inner ear morphology | 1.76e-04 | 303 | 39 | 6 | MP:0000026 | |
| MousePheno | macrophthalmia | 2.10e-04 | 8 | 39 | 2 | MP:0001296 | |
| MousePheno | abnormal renal glomerular capsule morphology | 2.17e-04 | 107 | 39 | 4 | MP:0002828 | |
| MousePheno | abnormal glucose tolerance | 2.49e-04 | 787 | 39 | 9 | MP:0005291 | |
| MousePheno | dilated glomerular capillary | 2.70e-04 | 9 | 39 | 2 | MP:0011509 | |
| MousePheno | kidney failure | 2.80e-04 | 46 | 39 | 3 | MP:0003606 | |
| MousePheno | expanded mesangial matrix | 2.80e-04 | 46 | 39 | 3 | MP:0011353 | |
| MousePheno | abnormal aortic valve cusp morphology | 2.99e-04 | 47 | 39 | 3 | MP:0010595 | |
| MousePheno | abnormal glomerular capillary morphology | 2.99e-04 | 47 | 39 | 3 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 3.18e-04 | 48 | 39 | 3 | MP:0011310 | |
| MousePheno | abnormal mesangial matrix morphology | 3.81e-04 | 51 | 39 | 3 | MP:0011338 | |
| MousePheno | abnormal blood circulation | 4.23e-04 | 845 | 39 | 9 | MP:0002128 | |
| MousePheno | kidney atrophy | 4.27e-04 | 53 | 39 | 3 | MP:0004970 | |
| MousePheno | renal interstitial fibrosis | 4.51e-04 | 54 | 39 | 3 | MP:0003215 | |
| MousePheno | vascular stenosis | 5.02e-04 | 56 | 39 | 3 | MP:0005412 | |
| MousePheno | abnormal heart left ventricle morphology | 5.07e-04 | 369 | 39 | 6 | MP:0003921 | |
| MousePheno | dilated capillary | 5.80e-04 | 13 | 39 | 2 | MP:0020326 | |
| MousePheno | total cataract | 5.80e-04 | 13 | 39 | 2 | MP:0010263 | |
| MousePheno | increased pancreatic islet cell apoptosis | 6.76e-04 | 14 | 39 | 2 | MP:0014121 | |
| MousePheno | hearing/vestibular/ear phenotype | 6.97e-04 | 905 | 39 | 9 | MP:0005377 | |
| MousePheno | abnormal membranous labyrinth morphology | 7.61e-04 | 262 | 39 | 5 | MP:0000035 | |
| MousePheno | increased urine protein level | 7.63e-04 | 149 | 39 | 4 | MP:0002962 | |
| MousePheno | abnormal kidney interstitium morphology | 8.50e-04 | 67 | 39 | 3 | MP:0011425 | |
| MousePheno | abnormal muscle cell glucose uptake | 8.50e-04 | 67 | 39 | 3 | MP:0004130 | |
| MousePheno | glomerulosclerosis | 8.88e-04 | 68 | 39 | 3 | MP:0005264 | |
| MousePheno | dilated vasculature | 9.66e-04 | 70 | 39 | 3 | MP:0004938 | |
| MousePheno | craniofacial phenotype | COL4A2 SFPQ OTX1 KMT2D COL11A1 COL11A2 GNAS LATS2 KCNH2 NOTCH1 COL27A1 | 9.84e-04 | 1372 | 39 | 11 | MP:0005382 |
| MousePheno | abnormal craniofacial morphology | COL4A2 SFPQ OTX1 KMT2D COL11A1 COL11A2 GNAS LATS2 KCNH2 NOTCH1 COL27A1 | 9.84e-04 | 1372 | 39 | 11 | MP:0000428 |
| MousePheno | decreased susceptibility to diet-induced obesity | 9.95e-04 | 160 | 39 | 4 | MP:0005659 | |
| MousePheno | abnormal pancreatic islet cell apoptosis | 1.00e-03 | 17 | 39 | 2 | MP:0009488 | |
| MousePheno | aorta stenosis | 1.00e-03 | 17 | 39 | 2 | MP:0010463 | |
| MousePheno | abnormal heart valve morphology | 1.07e-03 | 163 | 39 | 4 | MP:0000285 | |
| MousePheno | abnormal kidney vasculature morphology | 1.09e-03 | 73 | 39 | 3 | MP:0000530 | |
| MousePheno | increased phosphate level | 1.14e-03 | 166 | 39 | 4 | MP:0014545 | |
| MousePheno | increased circulating phosphate level | 1.14e-03 | 166 | 39 | 4 | MP:0001566 | |
| MousePheno | increased blood urea nitrogen level | 1.18e-03 | 289 | 39 | 5 | MP:0005565 | |
| MousePheno | abnormal urine protein level | 1.25e-03 | 170 | 39 | 4 | MP:0006315 | |
| MousePheno | glomerular crescent | 1.26e-03 | 19 | 39 | 2 | MP:0011506 | |
| MousePheno | kidney inflammation | 1.27e-03 | 171 | 39 | 4 | MP:0001859 | |
| MousePheno | renal fibrosis | 1.32e-03 | 78 | 39 | 3 | MP:0003985 | |
| MousePheno | lens vacuoles | 1.40e-03 | 20 | 39 | 2 | MP:0011697 | |
| MousePheno | abnormal lens capsule morphology | 1.40e-03 | 20 | 39 | 2 | MP:0003236 | |
| MousePheno | renal/urinary system inflammation | 1.54e-03 | 180 | 39 | 4 | MP:0011762 | |
| MousePheno | delayed kidney development | 1.54e-03 | 21 | 39 | 2 | MP:0000528 | |
| MousePheno | abnormal chondrocyte morphology | 1.58e-03 | 83 | 39 | 3 | MP:0000166 | |
| MousePheno | abnormal aorta elastic tissue morphology | 1.69e-03 | 22 | 39 | 2 | MP:0009862 | |
| MousePheno | abnormal urine homeostasis | 1.70e-03 | 466 | 39 | 6 | MP:0009643 | |
| MousePheno | decreased susceptibility to weight gain | 1.73e-03 | 186 | 39 | 4 | MP:0010182 | |
| MousePheno | increased insulin sensitivity | 1.80e-03 | 188 | 39 | 4 | MP:0002891 | |
| MousePheno | polyuria | 1.93e-03 | 89 | 39 | 3 | MP:0001762 | |
| MousePheno | impaired glucose tolerance | 1.98e-03 | 480 | 39 | 6 | MP:0005293 | |
| MousePheno | tubulointerstitial nephritis | 2.01e-03 | 24 | 39 | 2 | MP:0011405 | |
| MousePheno | abnormal blood vessel elastic tissue morphology | 2.01e-03 | 24 | 39 | 2 | MP:0006083 | |
| MousePheno | increased energy expenditure | 2.10e-03 | 196 | 39 | 4 | MP:0004889 | |
| MousePheno | bicuspid aortic valve | 2.18e-03 | 25 | 39 | 2 | MP:0010484 | |
| MousePheno | abnormal capillary morphology | 2.19e-03 | 93 | 39 | 3 | MP:0003658 | |
| MousePheno | dilated renal tubule | 2.77e-03 | 101 | 39 | 3 | MP:0002705 | |
| MousePheno | abnormal cellular glucose uptake | 2.85e-03 | 102 | 39 | 3 | MP:0003925 | |
| MousePheno | decreased circulating protein level | 2.85e-03 | 698 | 39 | 7 | MP:0014502 | |
| MousePheno | increased mesangial cell number | 2.94e-03 | 29 | 39 | 2 | MP:0011427 | |
| MousePheno | increased muscle cell glucose uptake | 2.94e-03 | 29 | 39 | 2 | MP:0030021 | |
| Domain | Collagen | COL3A1 MSR1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 3.74e-23 | 85 | 43 | 14 | IPR008160 |
| Domain | Collagen | COL3A1 MSR1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 3.74e-23 | 85 | 43 | 14 | PF01391 |
| Domain | C4 | 1.03e-16 | 6 | 43 | 6 | SM00111 | |
| Domain | - | 1.03e-16 | 6 | 43 | 6 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.03e-16 | 6 | 43 | 6 | IPR001442 | |
| Domain | C4 | 1.03e-16 | 6 | 43 | 6 | PF01413 | |
| Domain | NC1_IV | 1.03e-16 | 6 | 43 | 6 | PS51403 | |
| Domain | Fib_collagen_C | 2.33e-11 | 11 | 43 | 5 | IPR000885 | |
| Domain | COLFI | 2.33e-11 | 11 | 43 | 5 | PF01410 | |
| Domain | NC1_FIB | 2.33e-11 | 11 | 43 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 2.33e-11 | 11 | 43 | 5 | PD002078 | |
| Domain | COLFI | 2.33e-11 | 11 | 43 | 5 | SM00038 | |
| Domain | TSPN | 1.66e-09 | 23 | 43 | 5 | SM00210 | |
| Domain | CTDL_fold | 1.58e-07 | 107 | 43 | 6 | IPR016187 | |
| Domain | Laminin_G | 2.13e-07 | 58 | 43 | 5 | IPR001791 | |
| Domain | K_chnl_volt-dep_ERG | 1.55e-05 | 3 | 43 | 2 | IPR003967 | |
| Domain | - | 6.66e-05 | 95 | 43 | 4 | 2.60.120.200 | |
| Domain | Cadherin_tail | 8.36e-05 | 37 | 43 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 8.36e-05 | 37 | 43 | 3 | IPR031904 | |
| Domain | Laminin_G_2 | 1.06e-04 | 40 | 43 | 3 | PF02210 | |
| Domain | LamG | 1.41e-04 | 44 | 43 | 3 | SM00282 | |
| Domain | ConA-like_dom | 1.42e-04 | 219 | 43 | 5 | IPR013320 | |
| Domain | PAS_9 | 2.30e-04 | 10 | 43 | 2 | PF13426 | |
| Domain | Cadherin_2 | 4.49e-04 | 65 | 43 | 3 | PF08266 | |
| Domain | Cadherin_N | 4.49e-04 | 65 | 43 | 3 | IPR013164 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.63e-04 | 14 | 43 | 2 | IPR003938 | |
| Domain | PAS-assoc_C | 1.38e-03 | 24 | 43 | 2 | IPR000700 | |
| Domain | PAS | 1.50e-03 | 25 | 43 | 2 | PF00989 | |
| Domain | PAS_fold | 1.50e-03 | 25 | 43 | 2 | IPR013767 | |
| Domain | PAC | 1.62e-03 | 26 | 43 | 2 | IPR001610 | |
| Domain | PAC | 1.62e-03 | 26 | 43 | 2 | SM00086 | |
| Domain | PAC | 1.62e-03 | 26 | 43 | 2 | PS50113 | |
| Domain | Cadherin_CS | 2.01e-03 | 109 | 43 | 3 | IPR020894 | |
| Domain | CADHERIN_1 | 2.23e-03 | 113 | 43 | 3 | PS00232 | |
| Domain | Cadherin | 2.23e-03 | 113 | 43 | 3 | PF00028 | |
| Domain | CADHERIN_2 | 2.29e-03 | 114 | 43 | 3 | PS50268 | |
| Domain | - | 2.29e-03 | 114 | 43 | 3 | 2.60.40.60 | |
| Domain | CA | 2.35e-03 | 115 | 43 | 3 | SM00112 | |
| Domain | Cadherin-like | 2.40e-03 | 116 | 43 | 3 | IPR015919 | |
| Domain | CNMP_BINDING_1 | 2.46e-03 | 32 | 43 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.46e-03 | 32 | 43 | 2 | PS00889 | |
| Domain | Cadherin | 2.52e-03 | 118 | 43 | 3 | IPR002126 | |
| Domain | cNMP | 2.77e-03 | 34 | 43 | 2 | SM00100 | |
| Domain | PAS | 2.77e-03 | 34 | 43 | 2 | IPR000014 | |
| Domain | PAS | 2.77e-03 | 34 | 43 | 2 | PS50112 | |
| Domain | cNMP_binding | 2.77e-03 | 34 | 43 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 2.94e-03 | 35 | 43 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 2.94e-03 | 35 | 43 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 3.45e-03 | 38 | 43 | 2 | IPR018490 | |
| Domain | - | 5.46e-03 | 48 | 43 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 6.15e-03 | 51 | 43 | 2 | IPR014710 | |
| Domain | VWA | 7.37e-03 | 56 | 43 | 2 | PF00092 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 3.33e-25 | 44 | 34 | 13 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 1.58e-22 | 67 | 34 | 13 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL28A1 | 7.93e-21 | 41 | 34 | 11 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 9.88e-21 | 90 | 34 | 13 | M631 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 | 9.60e-20 | 32 | 34 | 10 | MM14924 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL27A1 | 1.02e-18 | 61 | 34 | 11 | M27103 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL28A1 | 1.02e-18 | 61 | 34 | 11 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL28A1 | 1.36e-17 | 76 | 34 | 11 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 | 1.49e-17 | 50 | 34 | 10 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 | 2.81e-17 | 53 | 34 | 10 | MM14566 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 | 8.97e-17 | 59 | 34 | 10 | M27218 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 | 2.15e-16 | 64 | 34 | 10 | M26953 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 | 1.45e-15 | 114 | 34 | 11 | MM14571 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 COL27A1 | 2.74e-15 | 300 | 34 | 14 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 | 1.47e-14 | 140 | 34 | 11 | M587 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.86e-14 | 20 | 34 | 7 | MM15061 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.58e-14 | 10 | 34 | 6 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.58e-14 | 10 | 34 | 6 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.66e-14 | 11 | 34 | 6 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.13e-13 | 12 | 34 | 6 | MM1526 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.15e-13 | 46 | 34 | 8 | M198 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.09e-13 | 13 | 34 | 6 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.09e-13 | 13 | 34 | 6 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.66e-13 | 14 | 34 | 6 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.66e-13 | 14 | 34 | 6 | M6487 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL28A1 | 4.20e-13 | 258 | 34 | 12 | MM14572 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.09e-13 | 15 | 34 | 6 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 6.09e-13 | 15 | 34 | 6 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.25e-12 | 18 | 34 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.25e-12 | 18 | 34 | 6 | MM14882 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.46e-12 | 66 | 34 | 8 | M18 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.94e-12 | 38 | 34 | 7 | MM14969 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 4.67e-12 | 20 | 34 | 6 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.24e-12 | 42 | 34 | 7 | M7169 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 6.36e-12 | 74 | 34 | 8 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.93e-12 | 76 | 34 | 8 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.93e-12 | 76 | 34 | 8 | MM14867 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.21e-11 | 23 | 34 | 6 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.21e-11 | 23 | 34 | 6 | MM1427 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.81e-11 | 84 | 34 | 8 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.99e-11 | 85 | 34 | 8 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 5.97e-11 | 57 | 34 | 7 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.77e-11 | 58 | 34 | 7 | M2049 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.04e-11 | 30 | 34 | 6 | M27216 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.24e-10 | 63 | 34 | 7 | M11187 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.43e-09 | 161 | 34 | 8 | M39770 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.19e-09 | 30 | 34 | 5 | M27772 | |
| Pathway | WP_FOCAL_ADHESION | 1.12e-08 | 187 | 34 | 8 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.82e-08 | 199 | 34 | 8 | M7253 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.23e-08 | 41 | 34 | 5 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 5.41e-08 | 43 | 34 | 5 | M53 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 9.82e-08 | 96 | 34 | 6 | M39834 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.07e-07 | 19 | 34 | 4 | M27221 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.07e-07 | 19 | 34 | 4 | MM15512 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A3 COL11A1 COL11A2 COL27A1 | 3.12e-07 | 532 | 34 | 10 | M27870 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A3 COL11A1 COL11A2 | 4.42e-07 | 418 | 34 | 9 | MM15587 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 4.52e-07 | 302 | 34 | 8 | M39719 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.39e-07 | 30 | 34 | 4 | MM15517 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.07e-07 | 326 | 34 | 8 | MM15917 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.19e-06 | 79 | 34 | 5 | M27643 | |
| Pathway | WP_CANCER_PATHWAYS | 2.20e-06 | 507 | 34 | 9 | M48302 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.41e-06 | 261 | 34 | 7 | MM15676 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.26e-06 | 43 | 34 | 4 | M39565 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.94e-05 | 67 | 34 | 4 | MM15345 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.58e-05 | 72 | 34 | 4 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.73e-05 | 73 | 34 | 4 | MM15906 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 4.03e-05 | 28 | 34 | 3 | MM15957 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.75e-05 | 84 | 34 | 4 | M3228 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 7.03e-05 | 439 | 34 | 7 | M42563 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 8.68e-05 | 98 | 34 | 4 | M27152 | |
| Pathway | WP_FOCAL_ADHESION | 1.06e-04 | 199 | 34 | 5 | M39402 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.41e-04 | 339 | 34 | 6 | M39736 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.62e-04 | 502 | 34 | 7 | MM14537 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.70e-04 | 45 | 34 | 3 | M39864 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.73e-04 | 575 | 34 | 7 | M29853 | |
| Pathway | WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT | 4.40e-04 | 62 | 34 | 3 | M45532 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.01e-03 | 325 | 34 | 5 | M12868 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.91e-03 | 27 | 34 | 2 | M27217 | |
| Pathway | REACTOME_REPRODUCTION | 2.35e-03 | 30 | 34 | 2 | MM17211 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.02e-03 | 34 | 34 | 2 | M39771 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 4.37e-03 | 41 | 34 | 2 | MM14546 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 4.79e-03 | 43 | 34 | 2 | M1056 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A3 KMT2D NOTCH1 | 5.63e-03 | 1432 | 34 | 9 | M509 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.70e-03 | 47 | 34 | 2 | MM14925 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL28A1 COL27A1 | 2.70e-20 | 175 | 43 | 13 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL3A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 | 9.82e-20 | 135 | 43 | 12 | 28675934 |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.48e-18 | 6 | 43 | 6 | 9506531 | |
| Pubmed | 2.48e-18 | 6 | 43 | 6 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.48e-18 | 6 | 43 | 6 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.48e-18 | 6 | 43 | 6 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.48e-18 | 6 | 43 | 6 | 6389236 | |
| Pubmed | 2.48e-18 | 6 | 43 | 6 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.48e-18 | 6 | 43 | 6 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.48e-18 | 6 | 43 | 6 | 9673377 | |
| Pubmed | 2.48e-18 | 6 | 43 | 6 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.48e-18 | 6 | 43 | 6 | 19275937 | |
| Pubmed | 2.48e-18 | 6 | 43 | 6 | 6988303 | ||
| Pubmed | 1.74e-17 | 7 | 43 | 6 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.74e-17 | 7 | 43 | 6 | 8006028 | |
| Pubmed | 1.74e-17 | 7 | 43 | 6 | 10416788 | ||
| Pubmed | 1.74e-17 | 7 | 43 | 6 | 1724753 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL3A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A3 COL11A2 COL27A1 | 5.33e-17 | 62 | 43 | 9 | 28344315 |
| Pubmed | 6.94e-17 | 8 | 43 | 6 | 3997552 | ||
| Pubmed | 6.94e-17 | 8 | 43 | 6 | 29422532 | ||
| Pubmed | 6.94e-17 | 8 | 43 | 6 | 10382266 | ||
| Pubmed | 2.08e-16 | 9 | 43 | 6 | 9878537 | ||
| Pubmed | 2.08e-16 | 9 | 43 | 6 | 12101409 | ||
| Pubmed | 5.19e-16 | 10 | 43 | 6 | 9136074 | ||
| Pubmed | 1.14e-15 | 11 | 43 | 6 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.14e-15 | 11 | 43 | 6 | 7500359 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 2.28e-15 | 12 | 43 | 6 | 12180907 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 2.28e-15 | 12 | 43 | 6 | 15837576 | |
| Pubmed | 2.28e-15 | 12 | 43 | 6 | 16024816 | ||
| Pubmed | 7.40e-15 | 14 | 43 | 6 | 12878203 | ||
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL4A5 COL4A6 COL5A3 ELN COL28A1 COL27A1 | 8.30e-15 | 167 | 43 | 10 | 22159717 | |
| Pubmed | 1.36e-14 | 6 | 43 | 5 | 7495302 | ||
| Pubmed | 1.97e-14 | 16 | 43 | 6 | 15878328 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 10639489 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 4.76e-14 | 7 | 43 | 5 | 10716744 | |
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 7521231 | ||
| Pubmed | 6.65e-14 | 19 | 43 | 6 | 15689378 | ||
| Pubmed | 1.27e-13 | 8 | 43 | 5 | 1377218 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.27e-13 | 8 | 43 | 5 | 10970885 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A6 ELN COL21A1 COL28A1 | 2.41e-13 | 153 | 43 | 9 | 25037231 | |
| Pubmed | 2.85e-13 | 9 | 43 | 5 | 8562707 | ||
| Pubmed | 5.61e-13 | 26 | 43 | 6 | 24742657 | ||
| Pubmed | 5.70e-13 | 10 | 43 | 5 | 9415455 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 1.04e-12 | 11 | 43 | 5 | 9731539 | |
| Pubmed | 1.79e-12 | 31 | 43 | 6 | 22925884 | ||
| Pubmed | 1.79e-12 | 12 | 43 | 5 | 8918877 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.02e-12 | 4 | 43 | 4 | 7827955 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 2.90e-12 | 13 | 43 | 5 | 9833687 | |
| Pubmed | 4.51e-12 | 14 | 43 | 5 | 19858219 | ||
| Pubmed | 6.76e-12 | 15 | 43 | 5 | 10625553 | ||
| Pubmed | 6.76e-12 | 15 | 43 | 5 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 6.76e-12 | 15 | 43 | 5 | 10706142 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 7.17e-12 | 79 | 43 | 7 | 18757743 | |
| Pubmed | 9.23e-12 | 40 | 43 | 6 | 27068110 | ||
| Pubmed | 1.01e-11 | 5 | 43 | 4 | 9409248 | ||
| Pubmed | 1.92e-11 | 18 | 43 | 5 | 9160753 | ||
| Pubmed | 4.55e-11 | 21 | 43 | 5 | 23325811 | ||
| Pubmed | 4.55e-11 | 21 | 43 | 5 | 27856617 | ||
| Pubmed | 7.07e-11 | 7 | 43 | 4 | 17418794 | ||
| Pubmed | 7.11e-11 | 186 | 43 | 8 | 20673868 | ||
| Pubmed | 7.11e-11 | 186 | 43 | 8 | 20452482 | ||
| Pubmed | 1.41e-10 | 8 | 43 | 4 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.41e-10 | 8 | 43 | 4 | 11867580 | |
| Pubmed | 1.41e-10 | 8 | 43 | 4 | 11683410 | ||
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 10880400 | ||
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 8995276 | ||
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 6.15e-10 | 34 | 43 | 5 | 16498405 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 1.76e-09 | 3 | 43 | 3 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 1.76e-09 | 3 | 43 | 3 | 15954103 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 3025878 | ||
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 1.76e-09 | 3 | 43 | 3 | 27859054 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 17396119 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 1.76e-09 | 3 | 43 | 3 | 34049963 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 24522496 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 6386565 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 3089234 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 7962065 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 1.76e-09 | 3 | 43 | 3 | 28542346 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 28704582 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 18930919 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 1.76e-09 | 3 | 43 | 3 | 30647093 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 38978054 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 20301386 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 36130833 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 14507670 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 1.76e-09 | 3 | 43 | 3 | 38433557 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 25575550 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 1.76e-09 | 3 | 43 | 3 | 27377778 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 24033287 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 14633121 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.26e-09 | 97 | 43 | 6 | 27559042 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 32945508 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 16192629 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 10722718 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 16041630 | ||
| Pubmed | 5.42e-08 | 30 | 43 | 4 | 20301299 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 23273220 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.35e-08 | 86 | 43 | 5 | 28327460 | |
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 9.82e-08 | 8 | 43 | 3 | 9382709 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 9.82e-08 | 8 | 43 | 3 | 20059976 | |
| Interaction | FBLN2 interactions | 1.13e-12 | 66 | 43 | 8 | int:FBLN2 | |
| Interaction | HABP2 interactions | 1.19e-12 | 18 | 43 | 6 | int:HABP2 | |
| Interaction | OSM interactions | 2.49e-12 | 20 | 43 | 6 | int:OSM | |
| Interaction | DCN interactions | 3.77e-10 | 43 | 43 | 6 | int:DCN | |
| Interaction | CD93 interactions | 5.02e-10 | 45 | 43 | 6 | int:CD93 | |
| Interaction | SERPINE2 interactions | 1.97e-09 | 56 | 43 | 6 | int:SERPINE2 | |
| Interaction | MMP9 interactions | 5.94e-09 | 67 | 43 | 6 | int:MMP9 | |
| Interaction | C1QTNF1 interactions | 4.99e-08 | 47 | 43 | 5 | int:C1QTNF1 | |
| Interaction | LAIR2 interactions | 6.19e-08 | 49 | 43 | 5 | int:LAIR2 | |
| Interaction | MATN2 interactions | 1.40e-07 | 113 | 43 | 6 | int:MATN2 | |
| Interaction | TGFBI interactions | 2.20e-07 | 25 | 43 | 4 | int:TGFBI | |
| Interaction | COLGALT2 interactions | 3.05e-07 | 67 | 43 | 5 | int:COLGALT2 | |
| Interaction | ANTXR2 interactions | 4.10e-07 | 29 | 43 | 4 | int:ANTXR2 | |
| Interaction | HDAC1 interactions | TRERF1 TXNIP RANBP2 ZNF217 TNRC18 SFPQ KMT2D LATS2 MGA FOLH1 GLI1 NOTCH1 | 2.25e-06 | 1108 | 43 | 12 | int:HDAC1 |
| Interaction | PLOD1 interactions | 2.57e-06 | 292 | 43 | 7 | int:PLOD1 | |
| Interaction | SAA1 interactions | 5.26e-06 | 54 | 43 | 4 | int:SAA1 | |
| Interaction | PCDHA10 interactions | 1.35e-05 | 22 | 43 | 3 | int:PCDHA10 | |
| Interaction | COL4A2 interactions | 1.96e-05 | 75 | 43 | 4 | int:COL4A2 | |
| Interaction | EGR2 interactions | 3.08e-05 | 171 | 43 | 5 | int:EGR2 | |
| Interaction | BGN interactions | 3.53e-05 | 30 | 43 | 3 | int:BGN | |
| Interaction | CHN2 interactions | 5.39e-05 | 97 | 43 | 4 | int:CHN2 | |
| Interaction | COL8A2 interactions | 9.80e-05 | 42 | 43 | 3 | int:COL8A2 | |
| Interaction | BMP3 interactions | 1.24e-04 | 8 | 43 | 2 | int:BMP3 | |
| Interaction | NID1 interactions | 1.46e-04 | 48 | 43 | 3 | int:NID1 | |
| Interaction | COL21A1 interactions | 1.59e-04 | 9 | 43 | 2 | int:COL21A1 | |
| Interaction | VHL interactions | 1.68e-04 | 561 | 43 | 7 | int:VHL | |
| Interaction | CRX interactions | 1.99e-04 | 254 | 43 | 5 | int:CRX | |
| Interaction | MAU2 interactions | 2.00e-04 | 136 | 43 | 4 | int:MAU2 | |
| Interaction | AR interactions | 2.03e-04 | 992 | 43 | 9 | int:AR | |
| Interaction | ARHGAP15 interactions | 2.71e-04 | 59 | 43 | 3 | int:ARHGAP15 | |
| Interaction | ARHGAP42 interactions | 2.84e-04 | 60 | 43 | 3 | int:ARHGAP42 | |
| Interaction | PRICKLE1 interactions | 2.84e-04 | 60 | 43 | 3 | int:PRICKLE1 | |
| Interaction | KCNH4 interactions | 2.90e-04 | 12 | 43 | 2 | int:KCNH4 | |
| Interaction | MFAP2 interactions | 2.90e-04 | 12 | 43 | 2 | int:MFAP2 | |
| Interaction | TRIM37 interactions | 3.42e-04 | 630 | 43 | 7 | int:TRIM37 | |
| Interaction | FN1 interactions | 3.72e-04 | 848 | 43 | 8 | int:FN1 | |
| Interaction | PCDHA7 interactions | 3.98e-04 | 14 | 43 | 2 | int:PCDHA7 | |
| Interaction | PCDHA2 interactions | 3.98e-04 | 14 | 43 | 2 | int:PCDHA2 | |
| Interaction | COL1A2 interactions | 6.16e-04 | 78 | 43 | 3 | int:COL1A2 | |
| Interaction | PLOD3 interactions | 6.16e-04 | 183 | 43 | 4 | int:PLOD3 | |
| Interaction | PCDHAC1 interactions | 7.43e-04 | 19 | 43 | 2 | int:PCDHAC1 | |
| Cytoband | 5q31 | 1.76e-04 | 115 | 43 | 3 | 5q31 | |
| Cytoband | Xq22 | 1.96e-04 | 22 | 43 | 2 | Xq22 | |
| Cytoband | 17q23.3 | 3.67e-04 | 30 | 43 | 2 | 17q23.3 | |
| Cytoband | 13q34 | 1.19e-03 | 54 | 43 | 2 | 13q34 | |
| Cytoband | 7q36.1 | 2.22e-03 | 74 | 43 | 2 | 7q36.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 2.76e-03 | 298 | 43 | 3 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 2.91e-03 | 85 | 43 | 2 | chr2q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 3.12e-03 | 88 | 43 | 2 | chr13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 5.70e-03 | 120 | 43 | 2 | chr17q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 9.81e-03 | 159 | 43 | 2 | chr7q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 1.14e-02 | 172 | 43 | 2 | chrXq22 | |
| GeneFamily | Collagens | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 1.50e-25 | 46 | 38 | 13 | 490 |
| GeneFamily | Clustered protocadherins | 3.27e-04 | 64 | 38 | 3 | 20 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.25e-03 | 25 | 38 | 2 | 775 | |
| GeneFamily | Potassium voltage-gated channels | 3.19e-03 | 40 | 38 | 2 | 274 | |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL21A1 COL28A1 COL27A1 | 4.16e-27 | 44 | 43 | 13 | M3005 |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 COL11A2 COL28A1 COL27A1 | 1.04e-24 | 43 | 43 | 12 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL28A1 COL27A1 | 8.39e-18 | 275 | 43 | 14 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL28A1 COL27A1 | 3.06e-16 | 270 | 43 | 13 | MM17057 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.60e-15 | 23 | 43 | 7 | M48001 | |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 ADAM20 COL28A1 COL27A1 | 3.80e-11 | 1026 | 43 | 15 | M5889 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.99e-11 | 40 | 43 | 6 | M5887 | |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 ADAM20 COL28A1 COL27A1 | 3.92e-10 | 1008 | 43 | 14 | MM17056 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.86e-07 | 385 | 43 | 8 | M39264 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.18e-07 | 81 | 43 | 5 | M39253 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.54e-07 | 268 | 43 | 7 | M45796 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP | 8.82e-07 | 200 | 43 | 6 | M8328 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 8.82e-07 | 200 | 43 | 6 | M5930 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 1.85e-06 | 15 | 43 | 3 | MM402 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 1.90e-06 | 362 | 43 | 7 | M39176 | |
| Coexpression | GU_PDEF_TARGETS_UP | 5.63e-06 | 71 | 43 | 4 | M3955 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 5.96e-06 | 72 | 43 | 4 | M45791 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 6.64e-06 | 74 | 43 | 4 | M13547 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.46e-05 | 29 | 43 | 3 | MM17055 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.67e-05 | 505 | 43 | 7 | M39167 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 1.95e-05 | 97 | 43 | 4 | M45794 | |
| Coexpression | PLASARI_TGFB1_TARGETS_1HR_DN | 2.62e-05 | 5 | 43 | 2 | M2444 | |
| Coexpression | PLASARI_TGFB1_TARGETS_1HR_DN | 2.62e-05 | 5 | 43 | 2 | MM943 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 2.83e-05 | 218 | 43 | 5 | M1099 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 3.36e-05 | 226 | 43 | 5 | M11238 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 3.55e-05 | 113 | 43 | 4 | M43610 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 3.93e-05 | 6 | 43 | 2 | M48000 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 4.05e-05 | 235 | 43 | 5 | MM978 | |
| Coexpression | LU_EZH2_TARGETS_DN | 4.60e-05 | 400 | 43 | 6 | M2140 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 5.20e-05 | 44 | 43 | 3 | M18274 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 5.43e-05 | 126 | 43 | 4 | M39132 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 TXNIP COL4A5 COL4A6 COL11A1 COL11A2 LATS2 NOTCH1 COL27A1 | 6.16e-05 | 1102 | 43 | 9 | M2369 |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.34e-05 | 47 | 43 | 3 | M7585 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 TXNIP COL4A5 COL4A6 COL11A1 COL11A2 LATS2 NOTCH1 COL27A1 | 7.17e-05 | 1124 | 43 | 9 | MM1070 |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 7.52e-05 | 137 | 43 | 4 | M40313 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 7.64e-05 | 50 | 43 | 3 | M7337 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 7.70e-05 | 439 | 43 | 6 | M39054 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 8.41e-05 | 141 | 43 | 4 | M10381 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES | 9.13e-05 | 144 | 43 | 4 | M41744 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 9.63e-05 | 146 | 43 | 4 | MM973 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 1.19e-04 | 58 | 43 | 3 | M178 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 1.32e-04 | 60 | 43 | 3 | M16524 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.43e-04 | 11 | 43 | 2 | M47997 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.47e-04 | 163 | 43 | 4 | M2769 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 1.56e-04 | 313 | 43 | 5 | M40228 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN | 1.58e-04 | 166 | 43 | 4 | M6110 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 1.58e-04 | 166 | 43 | 4 | M1542 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.91e-04 | 68 | 43 | 3 | M1373 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.11e-04 | 179 | 43 | 4 | MM660 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.27e-04 | 72 | 43 | 3 | MM1131 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.30e-04 | 767 | 43 | 7 | M39209 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP | 2.34e-04 | 184 | 43 | 4 | M3804 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 2.66e-04 | 76 | 43 | 3 | M11825 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.69e-04 | 352 | 43 | 5 | M17471 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 2.79e-04 | 355 | 43 | 5 | M45758 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 2.86e-04 | 795 | 43 | 7 | M39050 | |
| Coexpression | VEGF_A_UP.V1_UP | 2.92e-04 | 195 | 43 | 4 | M2676 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 2.97e-04 | 563 | 43 | 6 | M15103 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 2.98e-04 | 196 | 43 | 4 | M8683 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.98e-04 | 79 | 43 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.09e-04 | 80 | 43 | 3 | MM1285 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 3.10e-04 | 198 | 43 | 4 | M7948 | |
| Coexpression | DEMAGALHAES_AGING_DN | 3.11e-04 | 16 | 43 | 2 | M2145 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 3.13e-04 | 807 | 43 | 7 | M16651 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN | 3.16e-04 | 199 | 43 | 4 | M8313 | |
| Coexpression | GSE14026_TH1_VS_TH17_UP | 3.22e-04 | 200 | 43 | 4 | M3356 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_DC_UP | 3.22e-04 | 200 | 43 | 4 | M6271 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TCONV_UP | 3.22e-04 | 200 | 43 | 4 | M3234 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN | 3.22e-04 | 200 | 43 | 4 | M7993 | |
| Coexpression | HALLMARK_MYOGENESIS | 3.22e-04 | 200 | 43 | 4 | M5909 | |
| Coexpression | GSE27434_WT_VS_DNMT1_KO_TREG_UP | 3.22e-04 | 200 | 43 | 4 | M9620 | |
| Coexpression | GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP | 3.22e-04 | 200 | 43 | 4 | M7279 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN | 3.22e-04 | 200 | 43 | 4 | M7469 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.52e-04 | 17 | 43 | 2 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.52e-04 | 17 | 43 | 2 | M2223 | |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP | 3.82e-04 | 380 | 43 | 5 | M38974 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 3.83e-04 | 86 | 43 | 3 | M39247 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 3.96e-04 | 18 | 43 | 2 | M47984 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 5.91e-04 | 235 | 43 | 4 | M5311 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 6.19e-04 | 238 | 43 | 4 | M2020 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 6.49e-04 | 103 | 43 | 3 | M1170 | |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 6.49e-04 | 103 | 43 | 3 | M1967 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 6.67e-04 | 104 | 43 | 3 | M1318 | |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 7.05e-04 | 106 | 43 | 3 | MM1265 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 7.25e-04 | 107 | 43 | 3 | MM1130 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 8.06e-04 | 111 | 43 | 3 | MM1111 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 8.06e-04 | 111 | 43 | 3 | M45685 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 8.09e-04 | 681 | 43 | 6 | M39175 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1 | 8.61e-04 | 260 | 43 | 4 | M1273 | |
| Coexpression | TRAVAGLINI_LUNG_PERICYTE_CELL | 8.71e-04 | 114 | 43 | 3 | M41678 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 8.74e-04 | 261 | 43 | 4 | MM1277 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 8.79e-04 | 457 | 43 | 5 | M1613 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1 | 8.99e-04 | 263 | 43 | 4 | MM998 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 8.99e-04 | 27 | 43 | 2 | M1998 | |
| Coexpression | NGUYEN_NOTCH1_TARGETS_UP | 8.99e-04 | 27 | 43 | 2 | M15592 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 8.99e-04 | 27 | 43 | 2 | M14833 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_7_UP | 9.63e-04 | 118 | 43 | 3 | M2179 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 9.96e-04 | 470 | 43 | 5 | MM1053 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.01e-03 | 120 | 43 | 3 | M42505 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 1.06e-03 | 122 | 43 | 3 | M10276 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 2.36e-05 | 790 | 43 | 9 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 2.53e-05 | 797 | 43 | 9 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.58e-05 | 799 | 43 | 9 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.07e-04 | 234 | 43 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.36e-04 | 395 | 43 | 6 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.54e-04 | 404 | 43 | 6 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.88e-04 | 141 | 43 | 4 | gudmap_developingGonad_P2_ovary_1000_k1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-13 | 194 | 43 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL3A1 COL4A1 COL4A2 IL11RA COL4A5 COL5A3 COL11A1 ELN COL11A2 | 2.55e-13 | 198 | 43 | 9 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-10 | 176 | 43 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-10 | 176 | 43 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.16e-10 | 180 | 43 | 7 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.04e-10 | 185 | 43 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.44e-10 | 187 | 43 | 7 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.64e-10 | 188 | 43 | 7 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.07e-10 | 190 | 43 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.30e-10 | 191 | 43 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 6.53e-10 | 192 | 43 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 6.78e-10 | 193 | 43 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-10 | 195 | 43 | 7 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-10 | 197 | 43 | 7 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-10 | 198 | 43 | 7 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 8.39e-10 | 199 | 43 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.69e-10 | 200 | 43 | 7 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.69e-10 | 200 | 43 | 7 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.04e-08 | 161 | 43 | 6 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-08 | 162 | 43 | 6 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-08 | 162 | 43 | 6 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.24e-08 | 183 | 43 | 6 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.47e-08 | 186 | 43 | 6 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-08 | 188 | 43 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-08 | 188 | 43 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.72e-08 | 189 | 43 | 6 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-08 | 189 | 43 | 6 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-08 | 189 | 43 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-08 | 190 | 43 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-08 | 190 | 43 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-08 | 191 | 43 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-08 | 191 | 43 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-08 | 191 | 43 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-08 | 191 | 43 | 6 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.18e-08 | 194 | 43 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.18e-08 | 194 | 43 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-08 | 194 | 43 | 6 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-08 | 194 | 43 | 6 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-08 | 195 | 43 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-08 | 195 | 43 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-08 | 195 | 43 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.27e-08 | 195 | 43 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.27e-08 | 195 | 43 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-08 | 195 | 43 | 6 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-08 | 195 | 43 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | droplet-Heart-HEART|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-08 | 197 | 43 | 6 | 9654472f1d4c9a6caadf1ff61a84902d171e9eb4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-08 | 197 | 43 | 6 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.48e-08 | 197 | 43 | 6 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-08 | 197 | 43 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-08 | 197 | 43 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | droplet-Heart-HEART-1m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-08 | 197 | 43 | 6 | 1ec3c05a5d4163df2cf0d168e28a3f1d35364da2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-08 | 198 | 43 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.58e-08 | 198 | 43 | 6 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 198 | 43 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 198 | 43 | 6 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-08 | 198 | 43 | 6 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 198 | 43 | 6 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-08 | 199 | 43 | 6 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-08 | 199 | 43 | 6 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-08 | 199 | 43 | 6 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.69e-08 | 199 | 43 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-08 | 199 | 43 | 6 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.69e-08 | 199 | 43 | 6 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.69e-08 | 199 | 43 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-08 | 199 | 43 | 6 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.80e-08 | 200 | 43 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.80e-08 | 200 | 43 | 6 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.80e-08 | 200 | 43 | 6 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.80e-08 | 200 | 43 | 6 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.15e-08 | 113 | 43 | 5 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.15e-08 | 113 | 43 | 5 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-07 | 155 | 43 | 5 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-07 | 155 | 43 | 5 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.90e-07 | 162 | 43 | 5 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 6.04e-07 | 169 | 43 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-07 | 173 | 43 | 5 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.98e-07 | 174 | 43 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.18e-07 | 175 | 43 | 5 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-07 | 177 | 43 | 5 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 7.59e-07 | 177 | 43 | 5 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.81e-07 | 178 | 43 | 5 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-07 | 178 | 43 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.03e-07 | 179 | 43 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.25e-07 | 180 | 43 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-07 | 181 | 43 | 5 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-07 | 181 | 43 | 5 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 183 | 43 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 183 | 43 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.95e-07 | 183 | 43 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.95e-07 | 183 | 43 | 5 | 6b5eef96b28911c752a8b6c0975918c4572cec38 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.95e-07 | 183 | 43 | 5 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.19e-07 | 184 | 43 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-07 | 184 | 43 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-07 | 184 | 43 | 5 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.19e-07 | 184 | 43 | 5 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.19e-07 | 184 | 43 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 9.19e-07 | 184 | 43 | 5 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.44e-07 | 185 | 43 | 5 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-07 | 185 | 43 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-07 | 185 | 43 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.74e-06 | 50 | 26 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Adhesion molecules. | 1.91e-05 | 141 | 26 | 5 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Drug | GK-101 | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.13e-17 | 36 | 43 | 9 | CID000161853 |
| Drug | BAPN | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 7.93e-17 | 71 | 43 | 10 | CID000001647 |
| Drug | Madecassol | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.31e-16 | 46 | 43 | 9 | CID000108062 |
| Drug | d-indobufen | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 2.96e-16 | 50 | 43 | 9 | CID000044562 |
| Drug | ridogrel | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 4.33e-16 | 52 | 43 | 9 | CID005362391 |
| Drug | NSC49633 | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 5.21e-16 | 53 | 43 | 9 | CID000023340 |
| Drug | DMSe | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL5A3 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 7.99e-16 | 132 | 43 | 11 | CID000020796 |
| Drug | 4-hydroxyproline | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 1.08e-15 | 91 | 43 | 10 | CID000000825 |
| Drug | AC1LAKND | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 2.35e-15 | 62 | 43 | 9 | CID000470146 |
| Drug | hydroxylysine | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 6.97e-15 | 109 | 43 | 10 | CID000001029 |
| Drug | malotilate | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 8.54e-15 | 71 | 43 | 9 | CID000004006 |
| Drug | AC1NMZ1B | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.43e-14 | 75 | 43 | 9 | CID005034185 |
| Drug | strontium ranelate | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.84e-14 | 77 | 43 | 9 | CID006918182 |
| Drug | halofuginone lactate | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 4.63e-14 | 85 | 43 | 9 | CID000062891 |
| Drug | DL-penicillamine | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 8.37e-14 | 139 | 43 | 10 | CID000004727 |
| Drug | ticlopidine | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 2.76e-13 | 103 | 43 | 9 | CID000005472 |
| Drug | AC1L1C2F | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 5.05e-13 | 110 | 43 | 9 | CID000001711 |
| Drug | PPACK | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 6.47e-13 | 113 | 43 | 9 | CID003036757 |
| Drug | khellin | COL3A1 COL4A1 COL4A3 IL11RA COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 6.78e-13 | 171 | 43 | 10 | CID000003828 |
| Drug | AC1L9732 | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 7.01e-13 | 114 | 43 | 9 | CID000439300 |
| Drug | Tranilast sodium | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 7.60e-13 | 115 | 43 | 9 | CID000005527 |
| Drug | AC1L1DD6 | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 1.07e-12 | 179 | 43 | 10 | CID000002299 |
| Drug | Selara | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.63e-12 | 125 | 43 | 9 | CID000150310 |
| Drug | hyaluronan | COL3A1 COL4A1 COL4A3 IL11RA COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 1.64e-12 | 263 | 43 | 11 | CID000024759 |
| Drug | pirfenidone | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 4.02e-12 | 138 | 43 | 9 | CID000040632 |
| Drug | PCR 4099 | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 4.29e-12 | 139 | 43 | 9 | CID000002806 |
| Drug | candesartan cilexetil | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 6.29e-12 | 145 | 43 | 9 | CID000002540 |
| Drug | AC1Q6PCP | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 GNAS COL21A1 COL27A1 | 1.30e-11 | 230 | 43 | 10 | CID000005267 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.71e-11 | 162 | 43 | 9 | CID000072363 |
| Drug | prostacyclin sodium salt | DAB2IP COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 2.97e-11 | 250 | 43 | 10 | CID000000159 |
| Drug | isodesmosine | 3.36e-11 | 33 | 43 | 6 | CID000013811 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 6.83e-11 | 189 | 43 | 9 | CID000001413 |
| Drug | foscarnet | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 7.16e-11 | 190 | 43 | 9 | CID000003414 |
| Drug | 351A | 2.87e-10 | 20 | 43 | 5 | CID000122144 | |
| Drug | desmosine | 6.78e-10 | 53 | 43 | 6 | CID000025435 | |
| Drug | losartan | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 KCNH2 COL27A1 | 1.66e-09 | 378 | 43 | 10 | CID000003961 |
| Drug | silibinin | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 2.58e-09 | 285 | 43 | 9 | CID000005213 |
| Drug | chondroitin sulfate | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 3.89e-09 | 413 | 43 | 10 | CID000024766 |
| Drug | Sirius red | 5.88e-09 | 35 | 43 | 5 | CID005486818 | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 6.01e-09 | 314 | 43 | 9 | CID000447989 |
| Drug | dermatan sulfate | 7.25e-09 | 220 | 43 | 8 | CID000032756 | |
| Drug | AC1L18QD | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 8.11e-09 | 325 | 43 | 9 | CID000000213 |
| Drug | AC1L1KMJ | COL3A1 COL4A1 COL4A3 COL4A5 KCNH6 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.50e-08 | 476 | 43 | 10 | CID000030956 |
| Drug | PD123177 | 1.72e-08 | 43 | 43 | 5 | CID000114899 | |
| Drug | NC-4 | 1.94e-08 | 44 | 43 | 5 | CID006420119 | |
| Drug | pyridinoline | 3.10e-08 | 99 | 43 | 6 | CID000105068 | |
| Drug | colchine | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 3.34e-08 | 383 | 43 | 9 | CID000002833 |
| Drug | Y-27632 | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.18e-07 | 444 | 43 | 9 | CID000005711 |
| Drug | BPAT-143 | 1.25e-07 | 6 | 43 | 3 | CID000146249 | |
| Drug | LMWH | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 ELN COL11A2 COL21A1 COL27A1 | 3.30e-07 | 663 | 43 | 10 | CID000000772 |
| Drug | aspirin | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 8.64e-07 | 563 | 43 | 9 | CID000002244 |
| Drug | AC1MRIIV | 8.64e-07 | 39 | 43 | 4 | CID003518584 | |
| Drug | meticrane | 1.02e-06 | 11 | 43 | 3 | CID000004165 | |
| Drug | Curcumin | COL3A1 MSR1 COL4A1 COL4A2 COL4A5 SFPQ KCNH2 GLI1 NOTCH1 COL27A1 | 3.12e-06 | 850 | 43 | 10 | ctd:D003474 |
| Drug | N-(1-(2,3-dimethoxyphenyl)-4-methyl-3-penten-1-yl)-1-(5-bromofurfuryl)-1-piperidyl-4-amine | 3.48e-06 | 2 | 43 | 2 | ctd:C531033 | |
| Drug | trapidil | 4.05e-06 | 57 | 43 | 4 | CID000005531 | |
| Drug | AC1Q641C | 5.68e-06 | 62 | 43 | 4 | CID000005005 | |
| Drug | mitomycin C | 5.81e-06 | 241 | 43 | 6 | CID000005746 | |
| Drug | B-F-H | 6.99e-06 | 20 | 43 | 3 | CID000027690 | |
| Drug | CP-331 | 1.04e-05 | 3 | 43 | 2 | CID000130967 | |
| Drug | L-3,4-dehydroproline | 1.09e-05 | 73 | 43 | 4 | CID000094284 | |
| Drug | SIRIUS | 1.35e-05 | 77 | 43 | 4 | CID000091750 | |
| Drug | ethylnylestradiol | COL3A1 MSR1 TXNIP COL4A3 COL4A5 ZNF217 ELN COL11A2 GNAS COL21A1 COL27A1 | 1.49e-05 | 1251 | 43 | 11 | CID000003285 |
| Drug | LS-63783 | COL3A1 COL4A1 COL4A3 COL4A5 COL4A6 COL11A1 COL11A2 COL21A1 COL27A1 | 1.57e-05 | 804 | 43 | 9 | CID000000231 |
| Drug | pyrachlostrobin | MSR1 COL4A1 IL11RA COL4A5 COL4A6 COL5A3 COL11A1 LATS2 NOTCH1 | 1.68e-05 | 811 | 43 | 9 | ctd:C513428 |
| Drug | homocystine | 1.73e-05 | 82 | 43 | 4 | CID000010010 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.82e-05 | 83 | 43 | 4 | CID011968896 | |
| Drug | NS1643 | 2.09e-05 | 4 | 43 | 2 | CID010177784 | |
| Drug | Brn 2557402 | 2.09e-05 | 4 | 43 | 2 | CID000042742 | |
| Drug | AC1L9HPX | 2.73e-05 | 92 | 43 | 4 | CID000445279 | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.08e-05 | 193 | 43 | 5 | 3989_UP | |
| Drug | dimethylmalonimidate | 3.47e-05 | 5 | 43 | 2 | CID000189133 | |
| Drug | sophocarpine | 3.47e-05 | 5 | 43 | 2 | CID000115269 | |
| Drug | Cyclo-rgdphg | 3.47e-05 | 5 | 43 | 2 | CID006449872 | |
| Drug | ipriflavone | 3.47e-05 | 5 | 43 | 2 | ctd:C018986 | |
| Drug | Doxazosin | 5.20e-05 | 6 | 43 | 2 | DB00590 | |
| Drug | 4-fluoranylproline | 5.20e-05 | 6 | 43 | 2 | CID000450594 | |
| Drug | Prazosin | 5.20e-05 | 6 | 43 | 2 | DB00457 | |
| Drug | Diphosphonates | 5.20e-05 | 6 | 43 | 2 | ctd:D004164 | |
| Drug | Terazosin | 5.20e-05 | 6 | 43 | 2 | DB01162 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 6.79e-05 | 373 | 43 | 6 | ctd:C540355 | |
| Drug | AC1L9IOX | 7.27e-05 | 7 | 43 | 2 | CID000445868 | |
| Drug | AC1L1HWN | 7.27e-05 | 7 | 43 | 2 | CID000004323 | |
| Drug | HepII | 7.35e-05 | 43 | 43 | 3 | CID003036269 | |
| Drug | 1zd2 | 8.42e-05 | 45 | 43 | 3 | CID004149241 | |
| Drug | NSC27366 | 9.69e-05 | 8 | 43 | 2 | CID000231329 | |
| Drug | Miconazole | 9.69e-05 | 8 | 43 | 2 | DB01110 | |
| Drug | Sc 40827 | 9.69e-05 | 8 | 43 | 2 | CID000127918 | |
| Drug | azelastine | 1.24e-04 | 9 | 43 | 2 | ctd:C020976 | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 1.30e-04 | 52 | 43 | 3 | ctd:C573693 | |
| Drug | AC1L1HQG | 1.48e-04 | 142 | 43 | 4 | CID000004246 | |
| Drug | Ibutilide | 1.55e-04 | 10 | 43 | 2 | DB00308 | |
| Drug | WAY-123,398 | 1.55e-04 | 10 | 43 | 2 | CID000132160 | |
| Drug | 1h00 | 1.62e-04 | 56 | 43 | 3 | CID000445950 | |
| Drug | fluoride | 1.72e-04 | 278 | 43 | 5 | CID000014917 | |
| Drug | calcium phosphate | 1.78e-04 | 149 | 43 | 4 | CID000024441 | |
| Drug | angiotensin | 1.84e-04 | 282 | 43 | 5 | CID003083715 | |
| Drug | sodium chloride | 1.87e-04 | 865 | 43 | 8 | CID000000206 | |
| Drug | MBMP | 1.90e-04 | 11 | 43 | 2 | CID000150994 | |
| Drug | carbanilide | 1.90e-04 | 11 | 43 | 2 | CID000007595 | |
| Disease | collagen disease (implicated_via_orthology) | 3.59e-12 | 12 | 42 | 5 | DOID:854 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.25e-10 | 53 | 42 | 6 | C4707243 | |
| Disease | Alport syndrome | 2.68e-09 | 3 | 42 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 2.68e-09 | 3 | 42 | 3 | cv:CN076135 | |
| Disease | myopathy (implicated_via_orthology) | 7.47e-09 | 48 | 42 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | Hematuria, Benign Familial | 1.07e-08 | 4 | 42 | 3 | C0241908 | |
| Disease | Alport Syndrome | 1.07e-08 | 4 | 42 | 3 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 2.68e-08 | 5 | 42 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 2.68e-08 | 5 | 42 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 2.68e-08 | 5 | 42 | 3 | C1567744 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 1.98e-06 | 2 | 42 | 2 | C1839884 | |
| Disease | benign familial hematuria (is_implicated_in) | 1.98e-06 | 2 | 42 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Fibrochondrogenesis | 1.98e-06 | 2 | 42 | 2 | C0265282 | |
| Disease | Developmental Porencephaly | 1.98e-06 | 2 | 42 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 1.98e-06 | 2 | 42 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 1.98e-06 | 2 | 42 | 2 | C0302892 | |
| Disease | Alport syndrome, recessive type | 1.98e-06 | 2 | 42 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 1.98e-06 | 2 | 42 | 2 | C2931253 | |
| Disease | Porencephaly | 1.98e-06 | 2 | 42 | 2 | C4082173 | |
| Disease | PORENCEPHALY, FAMILIAL | 1.98e-06 | 2 | 42 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.98e-06 | 2 | 42 | 2 | C3281105 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 1.98e-06 | 2 | 42 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 1.98e-06 | 2 | 42 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 1.98e-06 | 2 | 42 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 1.98e-06 | 2 | 42 | 2 | cv:C0241908 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 1.98e-06 | 2 | 42 | 2 | C4551998 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.98e-06 | 2 | 42 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Leiomyoma, Epithelioid | 1.98e-06 | 2 | 42 | 2 | C0086533 | |
| Disease | Hereditary hearing loss and deafness | 2.03e-06 | 146 | 42 | 5 | cv:C0236038 | |
| Disease | Renal glomerular disease | 4.66e-06 | 23 | 42 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 4.66e-06 | 23 | 42 | 3 | C4521256 | |
| Disease | short QT syndrome (implicated_via_orthology) | 5.93e-06 | 3 | 42 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | Alport syndrome (is_implicated_in) | 5.93e-06 | 3 | 42 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 5.93e-06 | 3 | 42 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 5.93e-06 | 3 | 42 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 5.93e-06 | 3 | 42 | 2 | 614519 | |
| Disease | 1,5 anhydroglucitol measurement | 9.55e-06 | 29 | 42 | 3 | EFO_0008009 | |
| Disease | pulse pressure measurement | COL4A1 PCDHAC1 PCDHA10 PCDHA2 COL11A1 ELN LATS2 FOLH1 COL21A1 COL27A1 | 1.95e-05 | 1392 | 42 | 10 | EFO_0005763 |
| Disease | Stickler syndrome | 1.97e-05 | 5 | 42 | 2 | cv:C0265253 | |
| Disease | end stage renal disease (is_implicated_in) | 2.75e-05 | 41 | 42 | 3 | DOID:783 (is_implicated_in) | |
| Disease | hypertensive nephropathy | 2.96e-05 | 6 | 42 | 2 | C0848548 | |
| Disease | ANEURYSM, INTRACRANIAL BERRY, 1 (disorder) | 2.96e-05 | 6 | 42 | 2 | C1862932 | |
| Disease | Diffuse Large B-Cell Lymphoma | 6.68e-05 | 55 | 42 | 3 | C0079744 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 7.08e-05 | 9 | 42 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Hematuria | 7.08e-05 | 9 | 42 | 2 | C0018965 | |
| Disease | Aortic Aneurysm, Abdominal | 8.84e-05 | 10 | 42 | 2 | C0162871 | |
| Disease | long QT syndrome (implicated_via_orthology) | 8.84e-05 | 10 | 42 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | arterial stiffness measurement | 1.05e-04 | 64 | 42 | 3 | EFO_0004517 | |
| Disease | Connective Tissue Diseases | 1.53e-04 | 13 | 42 | 2 | C0009782 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 1.53e-04 | 13 | 42 | 2 | C0238288 | |
| Disease | Prostatic Neoplasms | 2.24e-04 | 616 | 42 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.24e-04 | 616 | 42 | 6 | C0376358 | |
| Disease | T-Cell Lymphoma | 2.34e-04 | 16 | 42 | 2 | C0079772 | |
| Disease | visceral adipose tissue measurement, body mass index | 2.62e-04 | 87 | 42 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | stroke outcome severity measurement | 5.78e-04 | 114 | 42 | 3 | EFO_0009603 | |
| Disease | Cerebral Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0334583 | |
| Disease | Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 5.81e-04 | 25 | 42 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 5.81e-04 | 25 | 42 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 6.29e-04 | 26 | 42 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 6.29e-04 | 26 | 42 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 6.29e-04 | 26 | 42 | 2 | C0334582 | |
| Disease | Nephrotic Syndrome | 6.79e-04 | 27 | 42 | 2 | C0027726 | |
| Disease | Anaplastic astrocytoma | 6.79e-04 | 27 | 42 | 2 | C0334579 | |
| Disease | Cerebral Hemorrhage | 7.30e-04 | 28 | 42 | 2 | C2937358 | |
| Disease | Malignant Neoplasms | 8.09e-04 | 128 | 42 | 3 | C0006826 | |
| Disease | spontaneous coronary artery dissection | 8.96e-04 | 31 | 42 | 2 | EFO_0010820 | |
| Disease | heart conduction disease (implicated_via_orthology) | 9.55e-04 | 32 | 42 | 2 | DOID:10273 (implicated_via_orthology) | |
| Disease | Bladder Neoplasm | 1.05e-03 | 140 | 42 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.07e-03 | 141 | 42 | 3 | C0005684 | |
| Disease | Focal glomerulosclerosis | 1.21e-03 | 36 | 42 | 2 | C0017668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPGTPGSSGPYGIKG | 811 | Q14031 | |
| GSSGPYGIKGKSGLP | 816 | Q14031 | |
| YGIKGKSGLPGAPGF | 821 | Q14031 | |
| LGYPGIPGAAGLKGQ | 141 | Q01955 | |
| KGYGGSADSGPPPKN | 666 | O43506 | |
| GDPGSYGSPGFPGLK | 311 | P53420 | |
| YNGPPGLQGFPGLQG | 71 | P08572 | |
| YPGLSGEKGSPGQKG | 306 | P08572 | |
| VTAQLPGAGGYPGGK | 141 | Q14565 | |
| PGLKGSPGSVGYPGS | 1096 | P02462 | |
| LQGDGYSGAKPIPGG | 1076 | P49792 | |
| YSGAKPIPGGQTIGP | 1081 | P49792 | |
| TFKYGPGNPKQSGPG | 866 | Q9Y5H9 | |
| YPVVTPNPKGGKGPG | 311 | Q5VWQ8 | |
| GPPGVQYGQPGRSVK | 31 | Q14626 | |
| SPNGYLGSLKPGVQG | 2141 | P46531 | |
| GGKGLPFYAGLSPAG | 1446 | Q8IWI9 | |
| YASLPTKGQGGPPGA | 286 | Q9NRM7 | |
| GSLKVPYNVGPGFTG | 321 | Q04609 | |
| DQIGKPYNSSGLGGP | 591 | Q12809 | |
| GPQFPSKGYSLLGPG | 751 | Q9H252 | |
| GLPGYPGRQGPKGST | 841 | P12107 | |
| PGYPGRQGPKGSLGF | 801 | P13942 | |
| AKAPVNTYGPGFGPN | 941 | P08151 | |
| KQPPYGMNGLGLAGP | 6 | P32242 | |
| GYAGRPGNSGPKGQK | 321 | P21757 | |
| TFKYGPGNPKQSGPG | 866 | Q9Y5I2 | |
| APYGPGPGQDKGFAT | 41 | P17509 | |
| TFKYGPGNPKQSGPG | 881 | Q9H158 | |
| YGSPGAPGIGQQGIK | 351 | Q2UY09 | |
| PGPPGYGSQGIKGEQ | 701 | Q2UY09 | |
| LPGIPGVSGPKGYQG | 971 | P29400 | |
| GLPGYPGNPGIKGSV | 1086 | P29400 | |
| GKPGYQGIAGTPGVP | 476 | Q96P44 | |
| SPGAKGYPGRQGLPG | 731 | Q8IZC6 | |
| KSGVAVGGLAGYPGP | 161 | P02461 | |
| PKLPGGYGLPYTTGK | 211 | P15502 | |
| PGYPGPRGVKGTSGN | 706 | P25940 | |
| GKVPSPGYGSPAAGA | 371 | Q5JWF2 | |
| GYQSGPAKAVRGPPQ | 261 | Q9ULL8 | |
| FSPPPVGGQGKEYPS | 1516 | Q9HCD6 | |
| YGETKGPGPTVKPSG | 291 | Q5VW32 | |
| GDPYGSGGQKFPPLG | 621 | P23246 | |
| KGQGPGGDGFYLPTA | 156 | O15417 | |
| PNVLTVQKPYGGSGP | 981 | O75362 | |
| PQGPLGTSFKGKYGC | 106 | Q9H3M7 | |
| SGSGGGGPKPYKCPE | 626 | Q9ULD5 | |
| PSGKQKPGGTQSGYC | 1051 | Q96PN7 | |
| FGPGPTLGKPQSTNY | 2566 | O14686 |